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Background
This study aims to investigate gene expression in skele-
tal muscle in relation to age and MH status, focussing
on particular genes of interest. Expression patterns have
been analysed to address the question of whether major
causative malignant hyperthermia (MH) mutations influ-
ence skeletal muscle ageing. In this context we have
examined gene expression in MH susceptible, both with
(MHS+) and without mutation (MHS-), and MH normal
(MHN) material from in vitro contracture test (IVCT)
muscle biopsies.
Material and methods and results
Affymetrix data, derived from Affymetrix HG_U133-
Plus2.0 arrays on a cohort of 59 patient muscle cDNA
samples, were analysed for potential genes of interest.
These 59 samples comprised an age range of 10-71
years and included 27 MHS+, 13 MHS- and 19 MHN.
Linear models (LM) were applied using R studio 3.0.1©.
LM1 incorporated three independent variables: age, sex
and malignant hyperthermia (MH) status and one
dependent variable, expression. LM2 included just the
sex and MH status variables, LM3 included only the age
and MH status and LM 4 included all 3 variables but
left out the age-MH status interaction term. Model
comparison was completed using Akaike Information
Criterion to establish the model that best fitted the
observed data. The results were interpreted to ascertain
those genes that may be of interest in the context of
age, MH status and interaction between these two
variables.
The genes selected through this process, along with
additional genes of interest based on criteria, such as
involvement in store-operated calcium entry (SOCE) in
skeletal muscle, were then subjected to TaqMan Gene
Expression Analysis on a cohort of 108 cDNA samples
(independent of the Affymetrix cohort) derived from
patient muscle biopsies. This group comprised indivi-
duals with ages ranging from 10-87 years and repre-
sented individuals susceptible to MH, including those
with a known mutation in RYR1 (42) and those with no
mutation in RYR1 (22), and those with a normal pheno-
type (44). The results were analysed in a similar manner
to the Affymetrix data, establishing any differences in
gene expression according to the three dependent vari-
ables; age, sex and MH status.
Conclusions
These results indicate a number of genes that may be of
interest in relation to skeletal muscle ageing and MH
status.
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